Polymorphisms of Genes Encoding Multidrug Resistance Proteins as a Predictive Factor for Second-Line Docetaxel Therapy in Advanced Non-small Cell Lung Cancer

Documenti analoghi

• The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings
  di: Kieszko, Robert, et al.
  Pubblicazione: (2015)
• Polymorphisms in the Gene Encoding Caspase 8 May Predict the Response to First-Line Platinum-Based Chemotherapy in Locally Advanced or Advanced Non-Small-Cell Lung Cancer
  di: Szczyrek, Michał, et al.
  Pubblicazione: (2021)
• Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer
  di: Krawczyk, Paweł, et al.
  Pubblicazione: (2012)
• The Application of Real-Time PCR Technique to Detect Rare Cell Clones with Primary T790M Substitution of EGFR Gene in Metastases of Non-small Cell Lung Cancer to Central Nervous System in Chemotherapy Naive Patients
  di: Powrózek, Tomasz, et al.
  Pubblicazione: (2014)
• Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine
  di: Mlak, Radosław, et al.
  Pubblicazione: (2018)